JAK2 and cyclic hematopoiesis: The proposed mechanism of increased cardiovascular disease risk has been more closely examined in relation to certain common CH-associated mutations, such as TET2 and JAK2. Enhanced inflammatory responses in monocytic, granulocytic, and lymphocytic cells have been suggested as contributing factors to the development of cardiovascular disease [11,16,17].